The utility of CD44, CD117 and CD133 in identification of cancer stem cells (CSC) in oral squamous cell carcinomas (OSCC)

Romanian Journal of Morphology and Embryology

Volumn 52, Issue 3 SUPPL., 2012, Pages 985-993

  Mǎrgǎritescu, Cl ^a   Pirici, D ^a   Simionescu, Cristiana ^a   Stepan, A ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Cancer stem cells; CD117; CD133; CD44; Oral squamous cell carcinoma

Indexed keywords

EID: 84865732644     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Stewart BW, Kleihues P (eds), World Cancer Report, WHO International Agency for Research on Cancer (IARC) Press, Lyon, 2003.
2. Petersen PE, The World Oral Health Report 2003: continuous improvement of oral health in the 21st century-the approach of the WHO Global Oral Health Programme, Community Dent Oral Epidemiol, 2003, 31(Suppl 1):3-23.
3. Petersen PE, Bourgeois D, Bratthall D, Ogawa H, Oral health information systems-towards measuring progress in oral health promotion and disease prevention, Bull World Health Organ, 2005, 83(9):686-693.
4. Jemal A, Siegel R, Xu J, Ward E, Cancer statistics, 2010, CA Cancer J Clin, 2010, 60(5):277-300.
5. Reid BC, Rozier RG, Continuity of care and early diagnosis of head and neck cancer, Oral Oncol, 2006, 42(5):510-516.
6. Aubele M, Werner M, Heterogeneity in breast cancer and the problem of relevance of findings, Anal Cell Pathol, 1999, 19(2):53-58.
7. Golub TR, Genome-wide views of cancer, N Engl J Med, 2001, 344(8):601-602.
8. Pardal R, Clarke MF, Morrison SJ, Applying the principles of stem-cell biology to cancer, Nat Rev Cancer, 2003, 3(12):895-902.
9. Reya T, Morrison SJ, Clarke MF, Weissman IL, Stem cells, cancer, and cancer stem cells, Nature, 2001, 414(6859):105-111.
10. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE, Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma, Proc Natl Acad Sci U S A, 2007, 104(3):973-978.
11. Misra S, Hascall VC, Berger FG, Markwald RR, Ghatak S, Hyaluronan, CD44, and cyclooxygenase-2 in colon cancer, Connect Tissue Res, 2008, 49(3):219-224.
12. Ghatak S, Misra S, Toole BP, Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells, J Biol Chem, 2005, 280(10):8875-8883.
13. Misra S, Toole BP, Ghatak S, Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells, J Biol Chem, 2006, 281(46):34936-34941.
14. Sheridan C, Kishimoto H, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S, Nakshatri H, CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis, Breast Cancer Res, 2006, 8(5):R59.
15. Omara-Opyene AL, Qiu J, Shah GV, Iczkowski KA, Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18, Lab Invest, 2004, 84(7):894-907.
16. Li Y, Heldin P, Hyaluronan production increases the malignant properties of mesothelioma cells, Br J Cancer, 2001, 85(4):600-607.
17. Corbeil D, Röper K, Hellwig A, Tavian M, Miraglia S, Watt SM, Simmons PJ, Peault B, Buck DW, Huttner WB, The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions, J Biol Chem, 2000, 275(8):5512-5520.
18. Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L, CD133+ cell selection is an alternative to CD34+cell selection for ex vivo expansion of hematopoietic stem cells, J Hematother Stem Cell Res, 2001, 10(2):273-281.
19. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL, Differentiation and expansion of endothelial cells from human bone marrow CD133(+) cells, Br J Haematol, 2001, 115(1):186-194.
20. Pfenninger CV, Roschupkina T, Hertwig F, Kottwitz D, Englund E, Bengzon J, Jacobsen SE, Nuber UA, CD133 is not present on neurogenic astrocytes in the adult subventricular zone, but on embryonic neural stem cells, ependymal cells, and glioblastoma cells, Cancer Res, 2007, 67(12):5727-5736.
21. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ, Prospective identification of tumorigenic prostate cancer stem cells, Cancer Res, 2005, 65(23):10946-10951.
22. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C, De Maria R, Identification and expansion of the tumorigenic lung cancer stem cell population, Cell Death Differ, 2008, 15(3):504-514.
23. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY, Identification and characterization of tumorigenic liver cancer stem/progenitor cells, Gastroenterology, 2007, 132(7):2542-2556.
24. O'Brien CA, Pollett A, Gallinger S, Dick JE, A human colon cancer cell capable of initiating tumour growth in immuno-deficient mice, Nature, 2007, 445(7123):106-110.
25. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB, Identification of human brain tumour initiating cells, Nature, 2004, 432(7015):396-401.
26. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D, Genetic progression model for head and neck cancer: implications for field cancerization, Cancer Res, 1996, 56(11):2488-2492.
27. Costea DE, Tsinkalovsky O, Vintermyr OK, Johannessen AC, Mackenzie IC, Cancer stem cells-new and potentially important targets for the therapy of oral squamous cell carcinoma, Oral Dis, 2006, 12(5):443-454.
28. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC, Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma, J Oral Pathol Med, 2007, 36(10):594-603.
29. Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, Hoang-Vu C, Schulze-Osthoff K, Los M, Cancer stem cells as targets for cancer therapy: selected cancers as examples, Arch Immunol Ther Exp (Warsz), 2008, 56(3):165-180.
30. Song J, Chang I, Chen Z, Kang M, Wang CY, Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling, PLoS One, 2010, 5(7):e11456.
31. Clay MR, Tabor M, Owen JH, Carey TE, Bradford CR, Wolf GT, Wicha MS, Prince ME, Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase, Head Neck, 2010, 32(9):1195-1201.
32. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF, Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma, Clin Cancer Res, 2008, 14(13):4085-4095.
33. Zhang Q, Shi S, Yen Y, Brown J, Ta JQ, Le AD, A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy, Cancer Lett, 2010, 289(2):151-160.
34. Herold-Mende C, Seiter S, Born AI, Patzelt E, Schupp M, Zöller J, Bosch FX, Zöller M, Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck, J Pathol, 1996, 179(1):66-73.
35. Oliveira DT, Odell EW, Expression of CD44 variant exons by normal oral epithelia, Oral Oncol, 1997, 33(4):260-262.
36. Hudson DL, Speight PM, Watt FM, Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them, Int J Cancer, 1996, 66(4):457-463.
37. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U, Expression and modulation of CD44 isoforms in humans, J Cell Biol, 1994, 124(1-2):71-82.
38. Simionescu C, Mǎrgǎritescu C, Surpǎţeanu M, Mogoantǎ L, Zǎvoi R, Ciurea R, Surlin P, Stepan A, The study of E-cadherine and CD44 immunoexpression in oral squamous cell carcinoma, Rom J Morphol Embryol, 2008, 49(2):189-193.
39. Kanke M, Fujii M, Kameyama K, Kanzaki J, Tokumaru Y, Imanishi Y, Tomita T, Matsumura Y, Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma, Arch Otolaryngol Head Neck Surg, 2000, 126(10):1217-1223.
40. Mack B, Gires O, CD44s and CD44v6 expression in head and neck epithelia, PLoS One, 2008, 3(10):e3360.
41. Ieta K, Tanaka F, Haraguchi N, Kita Y, Sakashita H, Mimori K, Matsumoto T, Inoue H, Kuwano H, Mori M, Biological and genetic characteristics of tumor-initiating cells in colon cancer, Ann Surg Oncol, 2008, 15(2):636-648.
42. Bertolini G, Roz L, Perego P, Tortoreto M, Fontanella E, Gatti L, Pratesi G, Fabbri A, Andriani F, Tinelli S, Roz E, Caserini R, Lo Vullo S, Camerini T, Mariani L, Delia D, Calabrò E, Pastorino U, Sozzi G, Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment, Proc Natl Acad Sci U S A, 2009, 106(38):16281-16286
43. Okamoto A, Chikamatsu K, Sakakura K, Hatsushika K, Takahashi G, Masuyama K, Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck, Oral Oncol, 2009, 45(7):633-639.
44. Felthaus O, Ettl T, Gosau M, Driemel O, Brockhoff G, Reck A, Zeitler K, Hautmann M, Reichert TE, Schmalz G, Morsczeck C., Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines, Biochem Biophys Res Commun, 2011, 407(1):28-33.
45. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, Bray RA, Waller EK, Buck DW, A novel fivetransmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning, Blood, 1997, 90(12):5013-5021.
46. Bidlingmaier S, Zhu X, Liu B, The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells, J Mol Med (Berl), 2008, 86(9):1025-1032.
47. Pötgens AJ, Schmitz U, Kaufmann P, Frank HG, Monoclonal antibody CD133-2 (AC141) against hematopoietic stem cell antigen CD133 shows crossreactivity with cytokeratin 18, J Histochem Cytochem, 2002, 50(8):1131-1134.
48. Florek M, Haase M, Marzesco AM, Freund D, Ehninger G, Huttner WB, Corbeil D, Prominin-1/CD133, a neural and hematopoietic stem cell marker, is expressed in adult human differentiated cells and certain types of kidney cancer, Cell Tissue Res, 2005, 319(1):15-26.
49. Shmelkov SV, Jun L, St Clair R, McGarrigle D, Derderian CA, Usenko JK, Costa C, Zhang F, Guo X, Rafii S, Alternative promoters regulate transcription of the gene that encodes stem cell surface protein AC133, Blood, 2004, 103(6):2055-2061.
50. Yu Y, Flint A, Dvorin EL, Bischoff J, AC133-2, a novel isoform of human AC133 stem cell antigen, J Biol Chem, 2002, 277(23):20711-20716.
51. Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, Prestegarden L, Røsland G, Thorsen F, Stuhr L, Molven A, Bjerkvig R, Enger PØ, CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells, Int J Cancer, 2008, 122(4):761-768.
52. Shen G, Shen F, Shi Z, Liu W, Hu W, Zheng X, Wen L, Yang X, Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods, In Vitro Cell Dev Biol Anim, 2008, 44(7):280-289.
53. Gunji Y, Nakamura M, Osawa H, Nagayoshi K, Nakauchi H, Miura Y, Yanagisawa M, Suda T, Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells, Blood, 1993, 82(11):3283-3289.
54. Miettinen M, Lasota J, KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation, Appl Immunohistochem Mol Morphol, 2005, 13(3):205-220.
55. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP, Identification and characterization of ovarian cancer-initiating cells from primary human tumors, Cancer Res, 2008, 68(11):4311-4320.
56. Di Meglio F, Castaldo C, Nurzynska D, Romano V, Miraglia R, Bancone C, Langella G, Vosa C, Montagnani S, Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart, J Mol Cell Cardiol, 2010, 49(5):719-727.
57. Deng W, Mesenchymal stem cells express c-kit, Circ Res, 2010, 107(10):e17; author reply e18.
58. Perrone F, Losa M, Lagonigro MS, Pilotti S, Expression of protein tyrosine kinases in head and neck squamous cell carcinomas, Am J Clin Pathol, 2006, 126(4):618.
59. Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A, Moll R, CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx, Virchows Arch, 2004, 444(3):231-234.